Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes
- 1 January 1996
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 70 (1) , 427-44
- https://doi.org/10.1128/jvi.70.1.427-444.1996
Abstract
We have studied genetic variation among clades A through E of human immunodeficiency virus type 1 (HIV-1) at the levels of antibody binding to gp120 molecules and virus neutralization. We are unable to identify neutralization serotypes that correspond to the genetic clades. Instead, we observe that inter- and intraclade neutralization of primary isolates by HIV-1-positive sera is generally weak and sporadic; some sera show a reasonable degree of neutralization breadth and potency whereas others are relatively sensitive to neutralization, but no consistent pattern was found. However, a few sera were able to neutralize across clades with significant potency, an observation which may have implications for the feasibility of a broadly effective HIV-1 vaccine involving humoral immunity. Serological assays measuring anti-gp120 antibody binding also failed to identify serotypes that correspond precisely to the genetic clades, but some indications of clade-specific binding were observed, notably with sera from clades B and E. A representative protein for each clade (A through E) was selected on the basis of its specificity, defined as high seroreactivity with sera from individuals infected with virus of that clade and lower reactivity with sera from individuals infected with viruses from other clades. The seroreactivity patterns against these five proteins could be used to predict the genotype of the infecting virus with moderate success.Keywords
This publication has 46 references indexed in Scilit:
- Correlation between Genetic and Biological Properties of Biologically Cloned HIV Type 1 Viruses Representing Subtypes A, B, and DAIDS Research and Human Retroviruses, 1995
- Genetic Variation of HIV Type 1 in Four World Health Organization-Sponsored Vaccine Evaluation Sites: Generation of Functional Envelope (Glycoprotein 160) Clones Representative of Sequence Subtypes A, B, C, and EAIDS Research and Human Retroviruses, 1994
- Standard Conditions of Virus Isolation Reveal Biological Variability of HIV Type 1 in Different Regions of the WorldAIDS Research and Human Retroviruses, 1994
- The World Health Organization Global Programme on AIDS Proposal for Standardization of HIV Sequence NomenclatureAIDS Research and Human Retroviruses, 1994
- Rapid Genetic Characterization of HIV Type 1 Strains from Four World Health Organization-Sponsored Vaccine Evaluation Sites Using a Heteroduplex Mobility AssayAIDS Research and Human Retroviruses, 1994
- HIV: Between Past and FutureAIDS Research and Human Retroviruses, 1994
- Early HIV Type 1 Strains in Thailand Were Not Responsible for the Current EpidemicAIDS Research and Human Retroviruses, 1994
- Characterization of Human Immunodeficiency Virus Type 1 Isolates from Children in Romania: Identification of a New Envelope SubtypeThe Journal of Infectious Diseases, 1994
- The Reactivities of HIV-1+Human Sera with Solid-Phase V3 Loop Peptides Can Be Poor Predictors of Their Reactivities with V3 Loops on Native gp120 MoleculesAIDS Research and Human Retroviruses, 1993
- Structural variability ofenv andgag gene products from a highly cytopathic strain of HIV-1Archiv für die gesamte Virusforschung, 1992